Friedreich's ataxia (FRDA) is caused by the reduced expression of the mitochondrial protein frataxin (FXN) due to an intronic GAA trinucleotide repeat expansion in the FXN gene. Although FRDA has no cure and few treatment options, there is research dedicated to finding an agent that can curb disease progression and address symptoms as neurobehavioral deficits, muscle endurance and heart contractile dysfunctions. Since oxidative stress and mitochondrial dysfunction are implicated in FRDA, we demonstrated the systemic delivery of catalysts activity of gold cluster superstructures (Au8-pXs) to improve cell response to mitochondrial reactive oxygen species (ROS) and thereby alleviate FRDA-related pathology in mesenchymal stem cells of FRDA patients. We also found that systemic delivery of Au8-pXs induced significant amelioration of motor function and cardiac contractility of YG8sR mouse model that recapitulates the FRDA phenotypes. These effects were linked to long-term improvement of mitochondrial functions and antioxidant cell responses. We coupled these events with increased expression of frataxin, which is sustained by reduced autophagy. Overall, these results suggest a cascade of Au8-pXs-related signals that encourage further optimization of the use of Au8-pXs in experimental clinical strategies for the treatment of FRDA.

Treatment with ROS detoxifying gold clusters alleviates the progressive functional decline in a mouse model of Friedreich’s Ataxia

Chiara Riganti;Rebecca Jones;Marina Boido;Claudio Medana;Carla Liaci;Giorgio Roberto Merlo;
2021

Abstract

Friedreich's ataxia (FRDA) is caused by the reduced expression of the mitochondrial protein frataxin (FXN) due to an intronic GAA trinucleotide repeat expansion in the FXN gene. Although FRDA has no cure and few treatment options, there is research dedicated to finding an agent that can curb disease progression and address symptoms as neurobehavioral deficits, muscle endurance and heart contractile dysfunctions. Since oxidative stress and mitochondrial dysfunction are implicated in FRDA, we demonstrated the systemic delivery of catalysts activity of gold cluster superstructures (Au8-pXs) to improve cell response to mitochondrial reactive oxygen species (ROS) and thereby alleviate FRDA-related pathology in mesenchymal stem cells of FRDA patients. We also found that systemic delivery of Au8-pXs induced significant amelioration of motor function and cardiac contractility of YG8sR mouse model that recapitulates the FRDA phenotypes. These effects were linked to long-term improvement of mitochondrial functions and antioxidant cell responses. We coupled these events with increased expression of frataxin, which is sustained by reduced autophagy. Overall, these results suggest a cascade of Au8-pXs-related signals that encourage further optimization of the use of Au8-pXs in experimental clinical strategies for the treatment of FRDA.
13
607
eabe1633
eabe1633
https://pubmed.ncbi.nlm.nih.gov/34408077/
Atassia Stress Ossidativo Nanoparticelle Modelli Animali
Chiara Villa, Mariella Legato, Alessandro Umbach, Chiara Riganti, Rebecca Jones, Beatrice Martini, Marina Boido, Claudio Medana, Irene Facchinetti, Dario Barni, Milena Pinto, Tania Arguello, Marzia Belicchi, Gigliola Fagiolari, Carla Liaci, Maurizio Moggio, Riccardo Ruffo, Carlos T. Moraes, Angelo Monguzzi, Giorgio Roberto Merlo, Yvan Torrente
File in questo prodotto:
File Dimensione Formato  
Villa et al 2021 Author Print.pdf

Accesso aperto con embargo fino al 31/12/2021

Descrizione: Authors PDF
Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 3.22 MB
Formato Adobe PDF
3.22 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1815324
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact